1. Introduction





2. Results and Discussion

Molecules | HOMO | LUMO | IP | BDE |
---|---|---|---|---|
CBD | −6.18 | −0.38 | 142.33 | 85.63 |
THC | −6.03 | −0.36 | 138.88 | 84.49 |
THC-1 | −6.04 | −0.51 | 138.86 | - |
THC-2 | −6.11 | −0.44 | 140.23 | 85.11 |
THC-3 | −6.03 | −0.31 | 138.92 | 84.94 |
THC-4 | −6.19 | −0.51 | 142.13 | 84.86 |
THC-5 | −6.16 | −0.31 | 140.63 | 85.68 |
THC-6 | −6.24 | −0.52 | 142.06 | 84.81 |
Phenol | −6.29 | −0.42 | 148.82 | 87.93 |
HPMC | −5.56 | −0.39 | 125.77 | 76.01 |
BHT | −5.97 | −0.36 | 136.71 | 78.48 |
HT | −6.25 | −0.64 | 142.54 | 84.86 |






3. Computational Methodology


4. Conclusions
Acknowledgments
Conflicts of Interest
References
- Di Marzo, V.; Bifulco, M.; de Petrocellis, L. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 2004, 3, 771–784. [Google Scholar] [CrossRef]
- Hohmann, A.G.; Suplita, R.L. II Endocannabinoid mechanisms of pain modulation. AAPS J. 2006, 8, E693–E708. [Google Scholar] [CrossRef]
- Walker, J.M.; Huang, S.M. Endocannabinoids in pain modulation. Prostaglands Leukot. Essent. Fatty Acids 2002, 66, 235–242. [Google Scholar] [CrossRef]
- Fox, A.; Bevan, S. Therapeutic potential of cannabinoid receptor agonists as analgesic agents. Expert Opin. Invest. Drugs 2005, 14, 695–703. [Google Scholar] [CrossRef]
- Meng, I.D.; Manning, B.H.; Martin, W.J.; Fields, H.L. An analgesia circuit activated by cannabinoids. Nature 1998, 395, 381–383. [Google Scholar] [CrossRef]
- Fox, A.; Kesingland, A.; Gentry, C.; McNair, K.; Patel, S.; Urban, L.; James, I. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 2001, 92, 91–100. [Google Scholar] [CrossRef]
- Russo, E.B.; Guy, G.W.; Robson, P.J. Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex(R), a Cannabis-Based Medicine. Chem. Biodivers. 2007, 4, 1729–1743. [Google Scholar] [CrossRef]
- Pertwee, R.G. The pharmacology of cannabinoid receptors and their ligands: An overview. Int. J. Obesity 2006, 30, S13–S18. [Google Scholar] [CrossRef]
- Hampson, A.J.; Grimaldi, M.; Axelrod, J.; Wink, D. Cannabidiol and (−)-8,9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. USA 1998, 95, 8268–8273. [Google Scholar] [CrossRef]
- Steffens, S.; Veillard, N.R.; Arnaud, C.; Pelli, G.; Burger, F.; Staub, C.; Karsak, M.; Zimmer, A.; Frossard, J.L.; Mach, F. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 2005, 434, 782–786. [Google Scholar]
- Ramírez, B.G.; Blázquez, C.; Gómez del Pulgar, T.; Guzmán, M.; de Ceballos, M.L. Prevention of Alzheimer’s disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation. J Neurosci. 2005, 25, 1904–1913. [Google Scholar] [CrossRef]
- Eubanks, L.M.; Rogers, C.J.; Beuscher, A.E., 4th; Koob, G.F.; Olson, A.J.; Dickerson, T.J.; Janda, K.D. A molecular link between the active component of marijuana and Alzheimer’s disease pathology. Mol. Pharmacol. 2006, 3, 773–777. [Google Scholar] [CrossRef]
- Munson, A.E.; Harris, L.S.; Friedman, M.A.; Dewey, W.L.; Carchman, R.A. Antineoplastic activity of cannabinoids. J. Nat. Cancer Inst. 1975, 55, 597–602. [Google Scholar]
- Preet, A.; Ganju, R.K.; Groopman, J.E. D9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 2007, 27, 339–346. [Google Scholar]
- Guzmán, M.; Duarte, M.J.; Blázquez, C.; Ravina, J.; Rosa, M.C.; Galve-Roperh, I.; Sánchez, C.; Velasco, G.; González-Faria, L. A pilot clinical study of 9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br. J. Cancer 2006, 95, 204–209. [Google Scholar] [CrossRef]
- Grant, I.; Gonzalez, R.; Carey, C.L.; Natarajan, L.; Wolfson, T. Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. J. Int. Neuropsychol. Soc. 2003, 9, 679–689. [Google Scholar]
- Jiang, W.; Zhang, Y.; Xiao, L.; Van Cleemput, J.; Ji, S.P.; Bai, G.; Zhang, X. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J. Clin. Invest. 2005, 115, 3104–3116. [Google Scholar] [CrossRef]
- Sarne, Y.; Mechoulam, R. Cannabinoids: Between neuroprotection and neurotoxicity. Curr. Drug Targets CNS Neurol. Disord. 2005, 4, 677–684. [Google Scholar] [CrossRef]
- Correa, F.; Mestre, L.; Molina-Holgado, E.; Arevalo-Martin, A.; Docagne, F.; Romero, E.; Molina-Holgado, F.; Borrell, J.; Guaza, C. The role of cannabinoid system on immune modulation: Therapeutic implications on CNS inflammation. Mini Rev. Med. Chem. 2005, 5, 671–675. [Google Scholar] [CrossRef]
- Fernández-Ruiz, J.; Romero, J.; Velasco, G.; Tolón, R.M.; Ramos, J.A.; Guzmán, M. Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci. 2007, 28, 39–45. [Google Scholar] [CrossRef]
- Pertwee, R.G. Cannabinoid Receptor Ligands. Available online: http://www.tocris.com/pdfs/pdf_downloads/Cannabinoid_Receptor_Ligands_Review.pdf (accessed on 4 October 2013).
- Huestis, M.A. Pharmacokinetics and Metabolism of the Plant Cannabinoids, Δ9-Tetrahydrocannibinol, Cannabidiol and Cannabinoids. Cannabinoids. Handb. Exp. Pharmacol. 2005, 168, 657–90. [Google Scholar]
- Leopoldini, M.; Russo, N.; Toscano, M. The molecular basis of working mechanism of natural polyphenolic antioxidants. Food Chem. 2011, 125, 288–306. [Google Scholar] [CrossRef]
- Galano, A.; Macías-Ruvalcaba, N.A.; Campos, O.N.M.; Pedraza-Chaverri. , J. Mechanism of the OH Radical Scavenging Activity of Nordihydroguaiaretic Acid: A Combined Theoretical and Experimental Study. J. Phys. Chem. B 2010, 114, 6625–6635. [Google Scholar] [CrossRef]
- Galano, A. On the direct scavenging activity of melatonin towards hydroxyl and a series of peroxyl radicals. Phys. Chem. Chem. Phys. 2011, 13, 7147–7157. [Google Scholar]
- Iuga, C.; Alvarez-Idaboy, J.R.; Russo, N. Antioxidant Activity of trans-Resveratrol toward Hydroxyl and Hydroperoxyl Radicals: A Quantum Chemical and Computational Kinetics Study. J. Org. Chem. 2012, 77, 3868–3877. [Google Scholar]
- Chiodo, S.G.; Leopoldini, M.; Russo, N.; Toscano, M. The inactivation of lipid peroxide radical by quercetin. A theoretical insight. Phys. Chem. Chem. Phys. 2010, 12, 7662–7670. [Google Scholar] [CrossRef]
- Leopoldini, M.; Chiodo, S.G.; Russo, N.; Toscano, M. Detailed Investigation of the OH Radical Quenching by Natural Antioxidant Caffeic Acid Studied by Quantum Mechanical Models. J. Chem. Theory Comput. 2011, 7, 4218–4233. [Google Scholar] [CrossRef]
- Leopoldini, M.; Marino, T.; Russo, N.; Toscano, M. Antioxidant Properties of Phenolic Compounds: H-Atom versus Electron Transfer Mechanism. J. Phys. Chem. A 2004, 108, 4916–4922. [Google Scholar] [CrossRef]
- Leopoldini, M.; Russo, N.; Toscano, M. Gas and Liquid Phase Acidity of Natural Antioxidants. J. Agric. Food Chem. 2006, 54, 3078–3085. [Google Scholar] [CrossRef]
- Leopoldini, M.; Russo, N.; Toscano, M. A comparative study of the antioxidant power of flavonoid catechin and its planar analogue. J. Agric. Food Chem. 2007, 55, 7944–7949. [Google Scholar] [CrossRef]
- Hamelink, C.; Hampson, A.; Wink, D.A.; Eiden, L.E.; Eskay, R.L. Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity. J. Pharmacol. Exp. Ther. 2005, 314, 780–788. [Google Scholar] [CrossRef]
- Queiroz, A.N.; Gomes, B.A.Q.; Moraes, W.M., Jr; Borges, R.S. A theoretical antioxidant pharmacophore for resveratrol. Eur. J. Med. Chem. 2009, 44, 1644–1649. [Google Scholar]
- Honório, K.M.; da Silva, A.B.F. An AM1 study on the electron-donating and electron-accepting character of biomolecules. Int. J. Quant. Chem. 2003, 95, 126–132. [Google Scholar] [CrossRef]
- Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Zakrzewski, V.G.; Montgomery, J.A.; Stratmann, R.E.; Burant, J.C.; et al. Gaussian 09, Revision C.02; Gaussian, Inc: Wallingford, CT, USA, 2004. [Google Scholar]
- Stewart, J.J.P. Optimization of parameters for semiempirical methods I. Method. J. Comput. Chem. 1989, 10, 209–220. [Google Scholar] [CrossRef]
- Kohn, W.; Becke, A.D.; Parr, R.G. Density functional theory of electronic structure. J. Phys. Chem. 1996, 100, 12974–12980. [Google Scholar] [CrossRef]
- Parr, R.G.; Pearson, R.G. Absolute hardness: Companion parameter to absolute electronegativity. J. Am. Chem. Soc. 1983, 105, 7512–7516. [Google Scholar] [CrossRef]
- Parr, R.G.; Szentpaly, L.V.; Liu, S. Electrophilicity index. J. Am. Chem. Soc. 1999, 121, 1922–1924. [Google Scholar] [CrossRef]
- Hehre, W.J.; Radom, L.; Schleyer, P.V.R.; Pople, J.A. Ab Initio Molecular Orbital Theory; Wiley: New York, NY, USA, 1986. [Google Scholar]
- Scalmani, G.; Frisch, M.J. A continuous surface charge formalism for the polarizable continuum model of solvation. J. Chem. Phys. 2010, 132, 114110. [Google Scholar] [CrossRef]
- Borges, R.S.; Queiroz, A.N.; Mendes, A.P.S.; Araújo, S.C.; França, L.C.S.; Franco, E.C.S.; Leal, W.G.; da Silva, A.B.F. Density Functional Theory (DFT) Study of Edaravone Derivatives as Antioxidants. Int. J. Mol. Sci. 2012, 13, 7594–7606. [Google Scholar] [CrossRef][Green Version]
- Mikulski, D.; Górniak, R.; Molski, M. A theoretical study of the structure-radical scavenging activity of trans-resveratrol analogues and cis-resveratrol in gas phase and water environment. Eur. J. Med. Chem. 2010, 45, 1015–1027. [Google Scholar] [CrossRef]
- Zhao, Y.; Truhlar, D.G. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: Two new functionals and systematic testing of four M06-class functionals and 12 other functionals. Theor. Chem. Acc. 2008, 120, 215–241. [Google Scholar] [CrossRef]
- Portmann, S.; Lüthi, H.P. Molekel: an interactive molecular graphics. Chimia 2000, 54, 766–770. [Google Scholar]
- Sample Availability: Not available.
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).